Atlas Trials

Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty

Clinical trial NCT04968392 · COMPLETED

Trial details

NCT number
NCT04968392
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Adductor Canal BlockLevobupivacaineDexmedetomidine
Start date
2019-03-01
Primary completion
2020-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.